Multivitamin and Micronutrient Management in Liver Cirrhosis

Empiric Multivitamin Supplementation

Fat‑Soluble Vitamins

Vitamin A

Vitamin D

Vitamin E

Vitamin K

Water‑Soluble Vitamins

Thiamine (Vitamin B1)

Vitamin B12

Folic Acid

Vitamin C

Trace Elements

Zinc

Selenium

Monitoring Strategy

Special Considerations

Beta‑Carotene Supplementation in Liver Cirrhosis – Safety and Guideline Recommendations

Cancer Risk Associated with High‑Dose Beta‑Carotene

• In smokers, high‑dose beta‑carotene supplementation significantly increased lung cancer incidence in randomized clinical trials (high‑quality evidence) 7.
• Among individuals who smoke, consume alcohol, or both, beta‑carotene supplementation raised the recurrence of colorectal adenomas (clinical‑trial evidence) 7.
• Cirrhotic patients already have a markedly elevated risk of hepatocellular carcinoma, so the added cancer risk from beta‑carotene is especially concerning (observational data) 8.

General Micronutrient Supplementation for Cirrhosis

• Standard oral multivitamins providing ≈100 % of the Daily Value are recommended for cirrhotic patients with frailty or sarcopenia (guideline‑level recommendation, strong) 9, 10.
• Such multivitamin regimens are inexpensive and essentially free of side effects when dosed at standard levels (guideline consensus) 9, 10.
• Routine screening for micronutrient deficiencies is advised in patients with advanced disease, cholestasis, or acute illness (guideline recommendation) 9, 10.

Vitamin A Management in Cirrhosis

• Fat‑soluble vitamin deficiencies, especially vitamin A, are common in cirrhosis; the majority of liver‑transplant candidates exhibit vitamin A deficiency (epidemiologic data) 11.
• When vitamin A deficiency is identified, correction should be performed with retinol (pre‑formed vitamin A) rather than high‑dose beta‑carotene (clinical‑nutrition guidance) 12.
• Serum retinol can be used to assess vitamin A status, although levels may fall during systemic inflammation (laboratory guidance) 12.

Contraindicated Supplements

• Manganese‑containing supplements should be avoided because cirrhotic patients accumulate total body manganese, which can deposit in the basal ganglia and cause neurotoxicity (guideline warning) 11.
• High‑dose single‑nutrient supplements exceeding 100 % of the Daily Value are not advised unless a specific biochemical deficiency has been documented (clinical‑trial evidence) 7.

Practical Algorithm for Patients Who Smoke or Use Alcohol

• Prescribe a manganese‑free standard multivitamin (one tablet daily) delivering ≈100 % of the Daily Value (clinical guideline) 13.
• Explicitly avoid high‑dose beta‑carotene (>100 % Daily Value) in these patients (clinical‑trial evidence) 7.
• If vitamin A deficiency is confirmed, supplement with retinol rather than beta‑carotene (combined hepatology and nutrition guidance) 11, 12.
• Counsel on smoking cessation and alcohol abstinence, as these behaviors amplify the cancer risk linked to beta‑carotene (clinical‑trial evidence) 7.